In humans, clinical studies have shown that high levels of IgM and IgG autoantibodies against apoB100 epitopes are associated with a lower risk of developing severe atherosclerosis and reduced cardiovascular risk [35]. The gene discussed is CD40LG; the disease is atherosclerosis.